In recent years, artificial intelligence (AI) has been one of the most talked-about technologies in the world, particularly in the medical and biotechnology space. As more companies move toward integrating AI into their workflows, the industry buzz has shifted from AI being a ‘buzzword’ to an essential tool in achieving rapid advancements in medical and… Continue reading 6 investors discuss why AI is more than just a buzzword in biotech